Penn medicine tests new ways to get more people screened for hereditary cancer risk
NCT ID NCT05721326
First seen Jan 18, 2026 · Last updated Apr 14, 2026 · Updated 10 times
Summary
This study tested different methods to encourage more people to get genetic testing for hereditary breast and ovarian cancer risk. Researchers used electronic health records to find over 1,300 eligible patients at Penn Medicine gynecology clinics. They tried sending messages directly to patients and alerts to their doctors to see which approach worked best to get people scheduled for genetic counseling and testing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.